86 results found.
9 pages of results.
... seeking approval to market REVLIMID as a treatment for transfusion-dependent patients with myelodysplastic syndromes (MDS) with a 5q deletion chromosomal abnormality. MDS is a malignant disorder of blood ...
Score: 28 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0032.htm
... seeking approval to market REVLIMID as a treatment for transfusion-dependent patients with myelodysplastic syndromes (MDS) with a 5q deletion chromosomal abnormality. MDS is a malignant disorder of blood ...
Score: 28 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0003.htm
... seeking approval to market REVLIMID as a treatment for transfusion-dependent patients with myelodysplastic syndromes (MDS) with a 5q deletion chromosomal abnormality. MDS is a malignant disorder of blood ...
Score: 28 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0080.htm
... seeking approval to market REVLIMID as a treatment for transfusion-dependent patients with myelodysplastic syndromes (MDS) with a 5q deletion chromosomal abnormality. MDS is a malignant disorder of blood ...
Score: 28 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0049.htm
... seeking approval to market REVLIMID as a treatment for transfusion-dependent patients with myelodysplastic syndromes (MDS) with a 5q deletion chromosomal abnormality. MDS is a malignant disorder of blood ...
Score: 28 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0038.htm
... Leukemia Cancer News- Return to Menu Arsenic Trioxide& MDS: Leukemia Arsenic trioxide in patients with myelodysplastic syndromes (MDS): Preliminary results of a phase II ...
Score: 27 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0012.htm
... Plenary Session http://www.celgene.com- 66% of Transfusion-Dependent Myelodysplastic Syndromes( MDS) Patients Achieved Transfusion Independence and a Median Hemoglobin Increase 5.3g/dl, on ...
Score: 26 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0062.htm
... MGI Pharmas Dacogen and Celgenes Revlimid are in pre-registration for treatment of myelodysplastic syndrome (MDS). However, the formers similar efficacy and toxicity to Pharmions Vidaza, the ...
Score: 26 - 8 Dec 2006 - URL: http://www.aplastic-anemia.org/aplastic-anemia-news/aplastic-anemia-news-0081.htm
... ) (arsenic trioxide) injection in a total of 120 patients with myelodysplasia (MDS) were presented at the 45th Annual Meeting of the American Society of Hematology. ...
Score: 24 - 8 Dec 2006 - URL: http://www.aplastic-anemia.org/aplastic-anemia-news/aplastic-anemia-news-0004.htm
... decitabine) appears to provide promising anti-cancer activity in the treatment of myelodysplastic syndromes( MDS). MDS is a disease in which the cells in a person's bone marrow ...
Score: 22 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0076.htm